Abbott - Cell-Dyne Ruby
by Abbott

Follow Us
DESCRIPTION

Hematology analyzer 

This instrument uses patented MAPSS technology to perform cell by cell analysis from a single dilution to enumerate and differentiate White Blood Cells and provide the performance needed for patient samples. Additionally, the instrument uses optical laser light scatter analysis, without the need to reflex to another test mode, to provide both the Red Blood Cell and Platelet counts.

FORUMSView All (4)
Ask a New Question

0

Replies
-WPalmer
10 months ago
Manual

requesting a copy of the Operators Manual 

Reply

1

Reply
-SKMR
4 years ago
screen is not working
hi what it could be the problem if the screen is not working . machine is working only the screen thank youReply

2

Replies
-rgrizzle
7 years ago
qc

does the open and closed modes have separate qc files or does it all go into one file?

Reply

FEATURES

  • MAPSS (Multi-angle, Polarized Scatter Separation) technology to provide accurate optical readings for WBCs with 5-part WBC differential. 
  • Cell by cell analysis using hydrodynamic focusing. 
  • Accurate WBC enumeration and identification using 4 angles of light scatter on up to 10,000 events per cycle. 
  • Multiple scatter plot analysis for identification of abnormal cells and interfering substances. 
  • Dual angle optical light scatter accurately enumerates and sizes platelets to reduce manual counts and blood smear reviews. 
  • Available full time with no need to repeat the sample in another test mode. 
  • Red Blood Cell counts including indices using 3 angles of light scatter, cell sphering and hydrodynamic focusing for accuracy.
  • Uses only 4 reagents including reticulocytes
  • Sampling: Open and Closed
  • Reagents: 3 and Retic
  • Load up Capacity: 50 tubes with 10 per rack
  • Maintenance Requirements: Auto-clean (15 min) daily and manual cleaning of syringes, shear valve, dil/sheath filter weekly

SPECIFICATIONS

Height32 in
Length 30 in
Weight235 lbs
Width20 in
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Please review our Privacy Policy for more details.
I Agree